+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 4
Age: 18Years - 50Years
FEMALE
ID00000448

Naltrexone Consummatory Behaviors in Alcoholic Women

Led by Yale University · Updated on 2014-05-07

160

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

This study will assess naltrexone's effectiveness in treating alcoholism in women and provide information on its potential value in treating eating disorders common among alcoholic women. Alcoholic women with and without both eating disorders and depression will be randomly assigned to placebo or naltrexone treatment. Each group will receive behavioral therapy for 12 weeks, with followup 6 months after treatment.

CONDITIONS

Brief Title

Naltrexone Treatment for Alcoholic Women

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here